operating activities 1,788 Net cash flows investing activities (2,101) Net cash flows financing activities 623 Net increase in cash and cash equivalents 310 Cash and cash equivalents at beginning of period
financial period, net cash was increased by 12.24 million Baht. This comprised of the following items: 1) Net cash received from Operating Activities totaling Baht 594.40 million Baht from the net income by
. The average collection period as at the end of this quarter was 95 days compared to 139 days as of 31 December 2018. The increase in average collection period was because of Trans.Ad Group ‘s
CMG revenues when goods are ready for transfer to customers (precisely after incubation period) and not when it has been transferred. This impacted the Company and its subsidiaries’ financial statement
recognize CMG revenues when goods are ready for transfer to customers (precisely after incubation period) and not when it has been transferred. This impacted the Company and its subsidiaries’ financial
Limited for the three months period ended March 31, 2019. And The Audited financial statement of BS Myco Biotech Company Limited for year ended December 31,2018. The calculation of transaction size (1) Book
the period ended (Kiosk) 129,948 130,109 130,053 129,208 129,011 Total average number of money transfer transactions (per day) 27,287 28,689 30,006 30,553 31,813 In 2Q19, FSMART is able to maintain as
/2017 4/2017 1/2018 2/2018 Total usage amount through "Boonterm Kiosk" (Million Baht) 8,779 9,311 10,084 10,421 10,611 Total number of "Boonterm Kiosk" as the period ended (Kiosk) 110,563 119,166 124,653
9.05 5.71 7.77 (0.97) 14.52 Profit before income tax expenses 34.41 46.63 23.08 31.41 (11.33) 32.93 Income tax expenses 3.57 4.84 3.95 5.38 0.38 10.64 Profit for the period 30.84 41.79 19.13 26.04 (11.71